Monthly Research Roundup: Cancer Care Predictions, Sun Safety, and More

May Research Roundup

Every day American Cancer Society researchers and scientists across the world are working to find cancer cures -- and better ways to treat and prevent the disease. Below are some of the interesting stories our researchers think you should know about from May 2015.

  • American Cancer Society research projects in the works: For Cancer Research Month this May, American Cancer Society researchers shared insights into some of the projects they are most excited about.
  • Sun safety for those with dark complexions: Caucasians of European ancestry with features such as dark eyes and hair and have certain mutations in a gene called MC1R are at increased risk for developing melanoma, the most aggressive type of skin cancer. This fact is not well known, something American Cancer Society grantee Peter Kanetsky, Ph.D., M.P.H., of the Moffitt Cancer Center is trying to change.
  • Cancer care of the future: 10 American Cancer Society Research Professors share their perspectives and predictions for how cancer research will evolve over the next 10 years – and what this might mean for patients.
  • A new way to stop melanoma from spreading: American Cancer Society-funded researcher Barbara Bedogni, Ph.D., at Case Western Reserve University, is studying the role of two specific molecules in the growth of melanoma. Based on initial research, Bedogni believes that these two molecules – called Notch1 and neuregulin1 – play a fundamental role in the growth and spread of melanoma cells. She hopes to find out whether inhibiting these two molecules can stop the melanoma growth and metastasis.
  • Promising drugs for EGFR-mutated lung cancers: Researchers are making progress against advanced non-small cell lung cancers that have mutations in the EGFR gene. Two studies in the April 30, 2015 issue of the New England Journal of Medicine show that 2 new EGFR inhibitors both show promise for people whose lung cancers are no longer responding to other EGFR inhibitors because of a new genetic mutation. 

American Cancer Society news stories are copyrighted material and are not intended to be used as press releases. For reprint requests, please see our Content Usage Policy.